This enduring activity offers key highlights of two expert faculty who discuss ways to improve dermatologists, rheumatologists, and APPs ability to evaluate emerging TYK2 inhibitor data and apply it to personalized treatment strategies for patients with psoriatic disease, including PsA, as they become available. As a result of this educational curriculum, learners should be better able to: 1. Discuss the rationale for using novel TYK2 inhibitors in the treatment of patients with psoriatic disease, including PsA; 2. Review the latest evidence on the use of novel TYK2 inhibitors in patients with psoriatic disease, including PsA; and, 3. Outline multidisciplinary strategies for the optimal integration of novel TYK2 inhibitors into treatment plans for patients with psoriatic disease, including PsA. Learners have access to downloadable materials for future use.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 27 Trinity Place, Suite 185
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- includes Online course / module
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedDec 30, 2025
-
Last day to claim creditDec 30, 2026 3 months left
-
PVI, PeerView Institute for Medical Education Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health
-
i3 Health Multidisciplinary Case Conference in Psoriatic Arthritis: Enhancing Outcomes with Oral Targeted Therapies
-
Group for Research And Assessment for Psoriasis and Psoriatic Arthritis (GRAPPA) +1 Beyond the Joints A WholeBody Approach to Psoriatic Arthritis Care Through Integrated Obesity Management
-
Answers in CME Inc. (AiCME) Beyond Biologics for Psoriasis and PsA: TYK2 Inhibitors and Practical Considerations for Personalizing Care
-
Answers in CME Inc. (AiCME) Redefining Oral Therapy in Psoriasis: TYK2 Inhibition in Focus
-
Answers in CME Inc. (AiCME) Small Molecules, Big Decisions: Where Do TYK2 Inhibitors Fit in Psoriasis Treatment?
